Testing for the presence of ANCAs in circulation is part of the clinical examinations routinely performed upon suspected autoimmune disorders, mainly vasculitis. The autoantibodies are typically directed toward neutrophil MPO or PR3. These are major granule-localized proteins, and similar to all hitherto-described ANCA antigens, they are expressed by all neutrophils, and ANCA-containing sera thus give rise to uniform reactivity toward all neutrophils in a sample. In this paper, we describe sera from 2 unrelated patients with diffuse inflammatory symptoms that gave rise to peculiar c-ANCA patterns, only reacting with a subpopulation (roughly 30%) of human neutrophils. By immunoblotting, both sera reacted to the same antigen, which was expressed in intracellular granules. The antigen could be released to the extracellular milieu through secretion but also through the formation of NETs. Neutrophils have long been considered a homogenous cell population, but it is becoming increasingly clear that distinct subpopulations, defined by the presence or absence of certain proteins, exist. One such marker that defines a neutrophil subset is the granule protein OLFM4. The unusual, subset-restricted c-ANCA sera reacted only with OLFM4-positive neutrophils, and MS analysis revealed that the autoantigen was, in fact, OLFM4. These data describe for the first time a c-ANCA pattern reactive to only a subpopulation of neutrophils and identify the granule protein OLFM4 as a novel autoantigen.
Introduction
Autoantibodies of different kinds are often associated with human disease, both as direct mediators of pathology and as biomarkers for diagnostic purposes. A special group of autoantibodies, so-called ANCAs, are typically directed to neutrophil granule proteins. The presence of ANCA in circulation is a serological hallmark of ANCA-associated, small-vessel vasculitides [1] , but ANCA may also be detected in a variety of other inflammatory diseases [2] . Clinical testing for the presence of ANCA in circulation is routinely performed upon suspected inflammatory and/or autoimmune pathology by an IIF technique, where diluted patient samples are incubated with ethanolfixed and -permeabilized human neutrophils to allow for specific ANCA binding [3] . After washing away nonspecific antibodies, the slides are incubated with a fluorescently labeled anti-human IgG antibody, and ANCA binding (and thereby, fluorescence) is detected by fluorescence microscopy. The staining patterns differ depending on the ANCA targets, and the most common autoantigens, PR3 or MPO, give rise to distinctly different staining patterns [4] . A fine, granular c-ANCA pattern is usually associated with anti-PR3 ANCA, whereas anti-MPO ANCA generally results in a p-ANCA-staining pattern. In addition to typical PR3 and MPO ANCA, a number of other specificities, as well as atypical ANCA-staining patterns, have been described [5] .
Regardless of the staining pattern displayed by ANCA-positive cells, common for all hitherto-described ANCA antigens is that all neutrophils are stained, indicating that the targeted antigens are expressed uniformly by all neutrophils. Traditionally, neutrophils have been viewed as a homogenous population of cells that all carry out the same functions, display the same properties, and are equipped with the same set of granule proteins. This makes sense, given that neutrophils are short lived and terminally differentiated; they do not divide after leaving the bone marrow. However, this view is gradually beginning to change [6, 7] , and it is becoming increasingly clear that distinct neutrophil subtypes, defined by the presence or absence of certain proteins, exist simultaneously in a given individual. Among the subtype markers described so far is CD177 (also known as HNA-2a), a membraneanchored glycoprotein that is expressed at the surface and in granules of a varying proportion (0-100%) of neutrophils [8] and the granule protein OLFM4. This glycosylated protein is known to be highly expressed in epithelial cells of the prostate, small intestine, and colon [9] and was recently demonstrated also to be expressed in a subset of human neutrophils, where it is localized to the specific granules of these cells [10] . We confirmed these findings [11] and also demonstrated that the relative proportion of OLFM4-expressing neutrophils is not altered by in vivo transmigration to tissues but reflects the relative abundance in circulation, i.e., roughly 10-50% [11, 12] .
During routine clinical testing for ANCA by use of IIF, we found that sera from 2 unrelated patients gave rise to unusual c-ANCA patterns, reactive to only a subpopulation of neutrophils, in contrast to conventional ANCA samples that stain 0 or 100% of the neutrophils. We demonstrate further that the target antigen for these sera is localized in the gelatinase and/or specific granules of neutrophils and identified the antigen as OLFM4. Our data disclose OLFM4 as a novel target antigen for ANCA and show that the presence of OLFM4-specific antibodies in sera gives rise to unusual, neutrophil subset-restricted c-ANCA patterns.
MATERIALS AND METHODS

Patient material
To obtain serum, blood was collected in serum-separating vacutainer tubes (Vacuette, serum clot activator; Greiner Bio-One, Kremsmünster, Austria). After allowing the blood to clot, serum was isolated by centrifugation for 10 min at 1200 g. Patient neutrophils were isolated from whole blood and collected in heparinized tubes, as described below. The study was approved by the Regional Ethical Board of Gothenburg, Sweden (No. 942-13), and written, informed consent was obtained from the participating patients. Cytokine concentrations, complement analyses, and Ig quantification were performed by accredited routine laboratory analyses (Clinical Immunology, Sahlgrenska University Hospital, Gothenburg, Sweden). Serum reactivity to PR3 and MPO was analyzed by capture ELISA (Euro Diagnostica, Malmö, Sweden).
Neutrophil isolation
Neutrophils were isolated from buffy coats from healthy blood donors (Blood Center, Sahlgrenska University Hospital) or from peripheral blood samples of patients and healthy controls. After removal of the erythrocytes by dextran sedimentation, isolation of the neutrophils was performed by Ficoll-Paque centrifugation, as described [13, 14] ; cells were washed twice and resuspended in Krebs-Ringer glucose phosphate buffer, supplemented with divalent cations (1 mM Ca 2+ and 1.5 mM Mg 2+ ), and stored on ice until use. The purity of the neutrophils obtained by this method was ;95%.
IIF staining of ANCA slides and cytospin preparations for microscopy
The presence of ANCA in sera was determined by use of an ANCA slide kit (ImmunoConcepts, Sacramento, CA, USA), according to the manufacturer's instructions, and slides were mounted by use of a DAPI-containing medium (ProLong Antifade; Molecular Probes, Eugene, OR, USA). If not stated differently, sera were used after dilution 1:20 in sample diluent. In-house ANCA slides that were attached to microscopic slides by cytospin centrifugation (Thermo Scientific, Waltham, MA, USA) were also prepared by use of neutrophils from healthy donors (isolated as described above). The slides were air dried, fixed with 70% ice-cold ethanol for 45 min, and washed with PBS before being subjected to IIF.
For IgG subclass analyses, ANCA slides (ImmunoConcepts) were incubated with ANCA-positive patient sera, as described above, followed by secondary mouse antibodies specific for IgG1 (Caltag, Buckingham, United Kingdom), IgG2, IgG3, or IgG4 (Sigma, St. Louis, MO, USA). A FITC-labeled goat antimouse F(ab9) 2 fragment was used for detection.
For costaining experiments, the ANCA-positive patient sera were mixed with a rabbit anti-human OLFM4 antibody (Product No. ab96280; Abcam, Cambridge, United Kingdom; 10 mg/ml) or a PE-conjugated mouse antihuman CD177 antibody (Product No. ab69777; Abcam; diluted 1:25) in sample diluent (from the ANCA kit), supplemented with 10% normal goat serum. Slides were incubated for 30 min in a humid chamber at room temperature, rinsed with PBS, and incubated with the secondary antibodies for OLFM4 [5 mg/ml Alexa Fluor 647-conjugated goat anti-rabbit F(ab9) 2 fragment; Molecular Probes] and ANCA (10 mg/ml FITC-conjugated goat anti-human IgG; Abcam) for 30 min in a humid chamber at room temperature. The slides were then rinsed with PBS and distilled water and mounted by use of ProLong Antifade with DAPI.
Images were captured by use of a confocal microscope (LSM 700; Zeiss, Oberkochen, Germany) and processed in Photoshop CS5.1. Isotype controls, negative ANCA serum (from the ANCA staining kit) or the omission of primary antibody, were used routinely to ensure specific binding of the antibodies and to adjust microscope settings.
Neutrophil secretion
Neutrophils isolated from buffy coats were left on ice (unstimulated control), incubated at 37°C with TNF-a (Sigma; 10 ng/mL) for 20 min, or incubated with cytochalasin B (Sigma; 5 mg/ml) for 5 min, followed by addition of ionomycin (Sigma; 5 3 10 27 M) for an additional 10 min. Microscopic cytospin slides were prepared, ethanol fixed, and immunostained as described above.
Induction of NET formation
In vitro formation of NETs was performed as described previously [11] . In short, isolated neutrophils were allowed to adhere to glass coverslips, and NET formation was induced by the addition of PMA (Sigma; 20 nM). After incubation for 3 h at 37°C with 5% CO 2 , slides were fixed and processed for IIF staining.
Subcellular fractionation
Subcellular fractionation of neutrophils was performed essentially as described [15] . In short, pooled neutrophils from 3 buffy coats were treated with the serine protease inhibitor diisopropyl fluorophosphate (Fluka, Seelze, Germany) and disrupted by nitrogen cavitation (Parr Instrument, Moline, IL, USA). After removal of intact cells and nuclei by low-speed centrifugation, the supernatant was layered onto a two-step Percoll gradient and centrifuged (17,000 g for 30 min at 4°C). Gradient fractions (1.5 mL each) were collected from the bottom of the centrifuge tube. Subsequently, granule-marker analysis was performed to determine the distribution of subcellular organelles in the fractions. The markers used were MPO (azurophil granules), b-cytochrome (gelatinase/specific granules), and ALP (secretory vesicles/plasma membrane). MPO content was determined by enzymatic activity, where fractions were incubated with o-phenylenediamine (Dako, Glostrup, Denmark) and hydrogen peroxide. ALP activity was measured by hydrolysis of p-nitro phenyl phosphate (Sigma) in a sodium barbital buffer in the presence of 0.4% Triton X-100 (Merck, Darmstadt, Germany). The b-cytochrome content was determined from the oxidized-reduced difference spectra (400-600 nm), recorded in a double-beam Lambda 2 spectrophotometer (PerkinElmer, Waltham, MA, USA) as described [16] .
Western blotting
The granule fractions with peak content of each of the markers were diluted in reducing sample buffer, boiled for 5 min, subjected to 8% SDS-PAGE, and transferred to polyvinylidene difluoride membranes (Immobilon P; Millipore, Bedford, MA, USA), which were blocked by use of 5% milk in TBST with 0.05% for 1 h, washed, and incubated with sera, diluted in blocking solution
(1/50) overnight at 4°C. The ANCA-negative serum from the ANCA kit described above was used as a negative control. After washing, membranes were incubated with 1.3 mg/ml HRP-labeled rabbit anti-human IgG antibody (Dako) for 2 h at room temperature. The membranes were washed and developed with peroxidase solution VIP (Vector Laboratories, Burlingame, CA, USA). From protein gels run in parallel, the gel pieces corresponding to the immunoreactive bands were excised and subjected to LC-MS/MS analyses (performed by the Proteomics Core Facility at Sahlgrenska Academy, University of Gothenburg, Sweden) with protein identification performed with the Mascot search engine (Matrix Science, London, United Kingdom) by use of the Human Swissprot Database (Swiss Institute of Bioinformatics, Basel, Switzerland). The Mascot significance threshold in the software was set to 95% and minimum numbers of peptides/protein to at least 2.
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RESULTS
Unusual ANCA patterns with reactivity toward a subset of neutrophils ANCA are autoantibodies associated with a number of different autoimmune conditions, and clinical testing for ANCA in serum is often performed by IIF assays by use of microscopic slides containing ethanol-fixed and permeabilized human neutrophils. Generally, ANCA-positive sera react to intracellularly localized neutrophil proteins and stain all cells to similar extents (Supplemental Fig 1) , indicating that the target antigen is expressed equally by all neutrophils.
During routine ANCA analyses, we found that sera from two independent patients (Patient/Serum #1 and #2) displayed strikingly unusual ANCA patterns, characterized by reactivity toward only a subpopulation of neutrophils; whereas some cells were completely devoid of staining, others displayed a distinct granular c-ANCA pattern (Fig. 1) . Serum titers of these unusual antibodies were quantified by dilution of the sera, and positive subset-restricted c-ANCA staining was present after dilution of the sera 1/640 (Serum #1), or 1/160 (Serum #2). Neither sera displayed reactivity to PR3 or MPO, as assessed by specific capture ELISAs (not shown).
Conventional ANCAs are predominantly of the IgG isotype [17] , and with the use of IgG subclass-specific secondary antibodies, we established that both sera contained IgG1 autoantibodies that resulted in the unusual subset-restricted c-ANCA pattern; secondary antibodies specific for IgG2, IgG3, or IgG4 gave negative ANCA IIF (data not shown).
Patient characteristics
Patient #1 was, at the time of the initial visit, an 82-year-old male having productive cough, dyspnea, and pleural effusion, and ANCA testing was ordered as part of the initial investigation. The patient developed a second episode of pleural effusion within 8 months. Both episodes were treated with pleurocentesis, resulting in blood-tinted fluid without any evidence of malignant cells or bacterial growth. Laboratory tests revealed only minor aberrations ( Table 1) with moderately increased CRP, minor changes in liver enzymes and eosinophil counts, and an homogenous, weak anti-dsDNA-positive ANA pattern. The patient also suffered from increasing physical and mental fatigue and episodes of a severely itching skin rash on the back, head, and lower legs. A dermatologist was consulted and diagnosed eczema. At present, the patient has no conclusive diagnosis, and explanations for the pleural effusions have not been found.
Patient #2 was, at the time of the initial visit, a 77-year-old male with hypertension and metformin-treated Type 2 diabetes. He suffered from weakness in his right hand and an inability to fully close this hand for a few months. An X-ray of the affected hand showed osteoarthrosis, and the patient was prescribed nonsteroidal anti-inflammatory drugs. However, the problems successively worsened with appearance of interstitial edema in both hands, accompanied by weakness in the shoulders and pain in the hip region. At this point, the ESR was slightly increased (Table 1) , and ANCA testing was ordered. The patient is currently under investigation, and possible differential diagnoses are seronegative rheumatoid arthritis or diabetic or paramalignant arthropathy.
The sera react with ∼30% of circulating neutrophils Quantification of the ANCA-positive cells by use of commercially available ANCA slides revealed that the 2 sera reacted to ;30% of neutrophils (Fig. 2) . Each lot of ANCA slides used in this study is a product of neutrophils from 1 single, healthy donor, and to verify our quantification results based on these slides, neutrophils from independent, healthy donors were cytospun, dried, ethanol fixed, and permeabilized before staining by use of Serum #1. The staining patterns were very similar on these slides, with the simultaneous presence of positive and negative neutrophils (Fig.  2) . Interindividual variation in terms of proportion of ANCApositive cells was higher than the variation between commercially available ANCA slides stained on different days, but the mean percentage of ANCA-positive neutrophils was similar (Fig. 2) . Furthermore, staining of in-house-prepared slides fixed with paraformaldehyde followed by saponin permeabilization resulted in an identical pattern (data not shown). These data show that the antigen recognized by this unusual subset-restricted c-ANCA is present or absent in neutrophils circulating simultaneously in peripheral blood of individual healthy donors. In addition, staining ANCA slides prepared with neutrophils isolated from Patient #1 with Serum #1 (i.e., patient neutrophils + patient serum) resulted in positive staining of 35% of neutrophils (data not shown).
The target antigen can be secreted or exposed on NETs For ANCA to develop, the (normally intracellular) target antigen must be exposed extracellularly, and thus, we investigated whether the antigen is lost from neutrophils after the triggering of conventional granule secretion. Neutrophils from 3 healthy donors were left unstimulated or incubated with TNF-a or a combination of ionomycin and the cytoskeletal-disrupting agent cytochalasin B. After that, the proportion of ANCA-positive cells was scored microscopically after staining with Serum #1. TNF-a triggers moderate secretion of the easily mobilized granules, and this treatment did not significantly alter the proportion of ANCA-positive neutrophils (Fig. 3A) . Treatment with ionomycin combined with cytochalasin B, on the other hand, is a supremely potent, albeit artificial, stimulation of secretion, and very few ANCA-positive cells were found after this treatment (Fig. 3A) , indicating that the antigen can be secreted and is likely a granule protein.
Another way by which intracellular molecules can be exposed is through the generation of NETs, a spectacular suicide program, whereby neutrophils release their own DNA covered by a variety of intracellular proteins, including histones and granule constituents [18] . We stimulated NET release in vitro by use of PMA and stained the extracellular fibrils by use of Serum #1. The detected antigen was associated to the extracellular DNA fibers, and in contrast to MPO, which is distributed evenly on all NETs [19] , local staining was only seen on a subpopulation of NETs (Fig. 3B) .
The target antigen is stored in gelatinase and/or specific granules
To identify the antigen(s) that gives rise to these unusual, subsetrestricted c-ANCA staining patterns, we first aimed at establishing in which subcellular compartment the protein is expressed. Isolated neutrophils were disintegrated by nitrogen cavitation and the nuclei removed by centrifugation, after which, the postnuclear supernatant was fractionated by use of a 2-layer Percoll density gradient [15] . This gradient enables the clear separation of azurophil granules (identified by MPO activity) from the gelatinase/specific granules (identified by b-cytochrome content) and the light membrane fraction (consisting of secretory vesicles and plasma membranes and identified by ALP activity; Fig. 4A ). Peak fractions for these three subcellular entities (Fractions 1, 8, and 17) were subjected to immunoblotting by use of the subset-restricted c-ANCA sera (Fig. 4B) . Each serum gave rise to 1 distinct band, and the bands detected by the 2 different sera were of the same molecular weight, indicating that both sera reacted to the same protein. The bands were present selectively in Fraction 8, corresponding to gelatinase/specific granules, and an ANCA-negative serum (negative control) did not react to any proteins in the fractions (Fig. 4B) . These data indicate that the target antigen is the same for both sera and that it is localized in gelatinase and/or specific granules.
The antigen is OLFM4, a newly described marker for a subset of neutrophils
To pinpoint the target antigen, the protein band corresponding to the Western blot band ( Fig. 4B ; Serum #1) was excised from a protein gel run in parallel, and subjected to LC-MS/MS analyses. As expected, with the use of such a sensitive technique on biologic samples containing multiple proteins of similar size, a range of proteins was identified in this band (top scores are shown in Table 2 ), including some major granule proteins known to be expressed by all neutrophils. The discrepancy between the theoretical molecular weights presented in Table 2 and the size in human neutrophil material is likely a result of mostly post-translational modifications of the proteins in vivo and the presence of breakdown products. Remarkably, one of the identified proteins was OLFM4, a protein that was recently shown by us [11] and others [10] to be expressed in only a subset of human neutrophils, where it is localized in specific granules. OLFM4 thus fits perfectly as the target antigen of the unusual subset-restricted c-ANCA patterns described herein. The staining of ANCA slides with an antibody directed to human OLFM4 resulted in distinct staining of only a subset (;30%) of the neutrophils (Fig. 5A) , and OLFM4 was also lost from cells after in vitro secretion in a very similar manner, as shown in Fig. 3A (unstimulated: 29.3 6 7.3% OLFM4-positive cells; TNF-a: 19.7 6 4.9% OLFM4-positive cells; ionomycin + cytochalasin B: 1.7 6 0.4% OLFM4-positive cells; mean 6 SD, n = 3). In addition, ANCA slides stained with an anti-OLFM4 antibody, in combination with either of the subset-restricted c-ANCA sera, resulted in complete colocalization (Fig 5B) . As a control, another established neutrophil subset marker, CD177 [20] , did not colocalize with the subset-restricted ANCA antigen, and the markers were clearly expressed independently of one another (Fig. 5C ). When leukocyte preparations containing PBMCs and polymorphonuclear cells were similarly stained by use of the patient sera, together with the OLFM4 antibody, there was, again, complete colocalization, with only a subset of the neutrophils and no other cell type staining positively (data not shown). Finally, when the cell line Pnt-2 (normal prostate epithelial cell line [21] ) and the cell line THP-1 (monocytic cell line [22] ) were stained with patient sera, together with OLFM4 antibody, only Pnt-2 reacted with the antibodies, displaying colocalization. This was as expected, as it is known that normal prostate epithelial cells express OLFM4 [23] . The THP-1 cells did not react with the sera or the OLFM4 antibodies ( Supplemental  Fig 2) . Together, these data strongly indicate that the target antigen that gives rise to the unusual subset-restricted c-ANCA staining is OLFM4.
DISCUSSION
The presence of ANCA in circulation is routinely tested upon suspected autoimmune and/or inflammatory conditions, and the targeted antigens are most often PR3 and MPO, major granule proteins of human neutrophils that are stored primarily in the azurophil granules of these cells [24] . When present in high titers, ANCA specific for PR3 (c-ANCA) or MPO (p-ANCA) are serological markers for systemic vasculitides, such as granulomatosis, with polyangiitis (Wegener's), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis [1] . However, a variety of other granule proteins can be targeted by autoantibodies, and these (non-PR3, non-MPO) ANCAs are often found in different infectious or inflammatory diseases [2] . Non-PR3, non-MPO ANCA antigens, which may give rise to c-ANCA, p-ANCA, or atypical ANCA-staining patterns, are most often granule proteins. Like PR3 and MPO, the antigens are expressed uniformly by all neutrophils.
The 2 sera investigated in this study caught our interest as a result of their strikingly unusual ANCA patterns, characterized by strong c-ANCA staining on a fraction of neutrophils, whereas other cells were devoid of staining. By subcellular fractionation of neutrophils, followed by immunoblotting with the sera, a distinct immunoreactive band was found. Based on the similarity between the bands obtained by the 2 different sera, we concluded that both sera recognize the same antigen, localized in gelatinase and/or specific granules. Proteomic analyses of the proteins present in the immunoreactive band identified a number of wellcharacterized granule proteins and among them, the newly described granule constituent OLFM4. This is the only protein on the list ( Table 2 ) that displays a bimodal expression in neutrophils [10, 11] , with the exception of cytochrome b-245 heavy-chain (Gp91 phox ) that is encoded on the X-chromosome. Gp91 phox may be expressed in fractions of neutrophils [25] , as a result of random X-chromosome inactivation from females carrying 1 copy of a defect cytochrome b-558 subunit b (CYBB) gene (i.e., mothers of patient with X-linked recessive chronic granulomatous disease). Such genetic defects are rare [26] , and our unusual ANCA sera displayed subtype reactivity to neutrophils isolated from all healthy donors tested (including commercially available ANCA slides). In addition, OLFM4 colocalized completely with the autoantigen recognized by the 2 sera. The discrepancy between the theoretical molecular weight of OLFM4, presented in Table 2 (57.2 kDa), and the size of the band in human neutrophil granule material shown in Fig. 4 (;75 kDa) is likely explained by post-translational modification of the protein, as it is known that OLFM4 is highly glycosylated in vivo [27] . The size of OLFM4 in human material found here by use of the unusual ANCA sera corresponds well to that published previously by us [11] and others [10] by Western blot by use of anti-OLFM4 antibodies.
In contrast to most other leukocytes, which are classified into a multitude of discrete subtypes that express different markers and function differently, neutrophils have long been regarded as a homogenous cell type, all equipped with the same granule proteins and carrying out similar functions. However, it is clear that also in neutrophils, expression levels of certain molecules may change during maturation in the bone marrow [28] or depending on the activation state of the cell. Some molecules are down-regulated by activation-induced proteolytic cleavage (e.g., L-selectin), and some are up-regulated to the surface as a result of activationinduced secretion (e.g., adhesion and/or chemotactic receptors). However, fundamentally different from these a Top-scoring proteins detected in excised gel pieces (from 2 independent subcellular fractionations) corresponding to the immunoreactive band obtained with Serum #1 (Fig. 4B) . Keratins (typical contaminants originating from hair and skin) have been removed from the list.
activation-induced alterations is the concept of bona fide neutrophil subtypes that exist side by side in the circulation of healthy individuals and that are defined by the presence or absence of certain proteins independently of activation or maturation status. The best-studied subpopulation marker is CD177, the expression of which varies from 0 to 100% on circulating neutrophils [29] . This glycoprotein is localized in the plasma membrane, as well as in intracellular granules of neutrophils [30] , and alloantibodies (i.e., antibodies directed to nonself antigens from the same species) directed to CD177 are important during a variety of clinical situations of alloimmunity, such as pregnancy, transplantation, and blood transfusions [31] . In addition, CD177 may play an indirect role in c-ANCA-mediated pathologies as a result of its ability to bind secreted PR3 and present it on the cell surface [32] . Our data clearly exclude CD177 as the autoantigen recognized by the sera characterized herein.
Another, more recently established neutrophil subpopulation marker is OLFM4, which was first identified in these cells by Borregaard and colleagues [10] , demonstrating OLFM4 gene transcription during myelopoiesis (with peak expression during the myelocyte/metamyelocyte stage of differentiation) and protein expression in the specific granules. More importantly, the same study also showed that OLFM4 is bimodally expressed in mature neutrophils, despite the fact that OLFM4 mRNA is present uniformly in all myelocytes/metamyelocytes during differentiation in the bone marrow. We later confirmed the simultaneous existence of OLFM4-positive and -negative neutrophils in circulation, corroborated the subcellular localization, and demonstrated further that whereas the relative proportion of these subtypes varies among individuals, it is not changed by in vivo transmigration to inflamed tissues, such as skin blisters [12] , skin chambers, or synovial fluid from rheumatic patients [11] . The function of OLFM4 in human neutrophils has not been determined, and the 2 neutrophil subtypes regulate cell death and phagocytosis similarly [11] . In mice, OLFM4 knockout animals have been shown to be more resistant to septic infections than wild-type mice, and the bactericidal capability of neutrophils was increased in the absence of OLFM4 [33, 34] . The authors explained this observation by showing that OLFM4 interacted with and inhibited the activity of cathepsin C [34] , a protease known to activate a number of other neutrophil proteases of importance for microbial killing (e.g., elastase and cathepsin G). It remains to be shown whether OLFM4-mediated inhibition of protease activity can also be beneficial under certain circumstances, and it is also not clear if OLFM4 expression is bimodal in neutrophils from (wild-type) mice.
The generation of autoantibodies to OLFM4 would require that this granule protein is exposed and presented extracellularly. This applies for all ANCA antigens, and a potential mechanism for this that presently receives a lot of interest is NET formation [35] . Regardless of whether programmed NET formation is of relevance in vivo, many of the conventional ANCA antigens are expressed on in vitro-generated NETs [36] , along with other autoantigens, such as histones and DNA [37] . OLFM4 is a constituent of NETs triggered by certain autoantibodies [38] , as well as PMA-induced NETs, where DNA-associated extracellular reactivity is distinct in (a subpopulation of) NETs by use of anti-OLFM4 antibodies [11] or ANCA serum (this study). We found that OLFM4-containing and autoreactive NETs were also formed in vitro by neutrophils isolated from Patient #1 (data not shown), and thus, NET formation may be a mechanism whereby OLFM4 is able to give rise to autoreactivity. Conventional secretion of OLFM4 required very strong stimulation (ref. [11] and this study) and is likely not the major mechanism behind extracellular release under physiologic settings.
The attempt to link OLFM4 ANCA to disease is by no means trivial. The 2 patients' symptoms and clinical statuses were rather vague, and apart from obscure inflammatory symptoms, the cases lack distinct common denominators. At present, there is no conclusive diagnosis for these patients, and they are subjected to further follow-up. This is, to our knowledge, the first report of c-ANCA with reactivity to a subpopulation of neutrophils. Thus, even though we cannot presently associate OLFM4 ANCA with pathology, the possible involvement of OLFM4 ANCA (and/or OLFM4 protein and/or the OLFM4-defined neutrophil subpopulations) warrants further investigations. OLFM4 differs from the classic ANCA target antigens MPO and PR3 in that it is not only expressed by neutrophils. Zhang et al. [27] reported expression in myeloid precursor cells, as well as in prostate, small intestine, colon, stomach, and bone marrow tissue. This may, of course, have implications for the potential significance of the novel ANCA that we describe, as the autoantibodies could potentially react also with these cells and tissue types.
During routine ANCA testing at our Clinical Immunology Laboratory, the 2 sera described in this report were found over a time period of 2 yr among a total of ;7000 ANCA samples. Thus, OLFM4 autoantibodies are rare but would be anticipated also to appear at other centers. During this period, we have also identified a handful of ANCA samples that suggests the existence of additional neutrophil subsets (distinct from those defined by the presence/absence of OLFM4 and CD177) that have not yet been described and characterized. We are currently investigating these sera to identify the target antigens.
Neutrophil heterogeneity is a relatively new idea, and the biologic finesse behind the existence of distinct neutrophil subtypes is still not clear. As of yet, limited numbers of subtype markers are characterized and defined, but the analyses of unusual ANCA sera with bimodal reactivity will likely lead to the identification of additional, novel subtype markers in the future. AUTHORSHIP F.A., P.T., and A.W. conducted experiments. Results were analyzed by F.A., P.T., C.D., A.W., and J.B.. P.T., B.A.A., R.P., and B.P. were in charge of clinical analyses and patient evaluation. A.W. and J.B. designed the study. F.A., P.T., A.W., and J.B. wrote the paper with input from all authors.
